Innovus Pharmaceuticals Inc. (fka INNV)

[Biotech Pharmer]

Boo, first it was "15M for 2017." Then it changed to $10-$15M for 2017"(a potential and likely miss of original guidance by 33%!) Then it was "exiting 2017 in profitability." Now it's "we'll give em to mid 2018." These penny stocks are always "we're right around the corner to ......" You are right, the revs are key, as well as reducing SG&A. Anyone can spend $1.50 to earn $1.00 The chart is horrible, the original ANDA is over 3 years old and MIA, and profitability is a mirage. The stock is down 72% from a year ago. You guys can spin this stuff all you want and tell me I don't understand. The facts are the facts and building shareholder value is something that escapes this management team.